Oral Anticoagulation in Patients with Acute Stroke and Atrial Fibrillation

Author:

,ABDULAN Irina Mihaela,LEON Maria Magdalena, ,MAȘTALERU Alexandra, ,IVAN Laura-Cristina, ,MITU Florin,

Abstract

Introduction. Patients who have experienced acute ischemic stroke (AIS) and have atrial fibrillation (AF) are often prescribed oral anticoagulants (OACs) to lower their risk of recurrent stroke or vascular embolism. This therapy is rarely advised as a preventive measure for reducing the risk of recurrent ischemic stroke associated with non-valvular atrial AF. The ideal timing for initiating oral anticoagulation in these patients remains uncertain. Methods. Research was conducted in the major medical databases containing articles. The following terms were used: atrial fibrillation, acute ischemic stroke, oral anticoagulants, stroke recurrence, and prevention. We excluded studies performed earlier than 10 years since the medical information was no longer valid in practice. Results. Information gathered from observational studies and control groups in randomized trials indicates that the early recurrence rate following an atrial fibrillation-related ischemic stroke falls within the range of approximately 0.5% to 1.3% per day during the initial two weeks. The research targeted adults (aged ≥18 years) with AF and a recent ischemic stroke (IS) (occurring within 72 hours of symptom onset) who satisfied the criteria for and were amenable to starting treatment with NOACs. Atrial fibrillation encompassed paroxysmal, persistent, and permanent forms, whether they were pre-existing conditions or diagnosed during the initial hospitalization. Observational studies indicate that the risk of recurrent stroke is seven times higher than the risk of hemorrhagic transformation during the early phase after a recent stroke. Conclusions. Early prevention treatments are critical because the acute phase after an ischemic stroke increases the risk of stroke recurrence. It is critical to balance the possible benefits of early oral anticoagulation against the dangers of developing intracerebral hemorrhage or hemorrhagic transformation of the ischemic injury at this critical time.

Publisher

Academia Oamenilor de Stiinta din Romania

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3